Skip to main content
Equibles
TMO logo

TMO · Thermo Fisher Scientific Inc. · Metrics

Track TMO — free

Use TMO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TMO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$662.00 -25.37 (-3.69%) Earnings today
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$251.20B
Shares
369.75M
Volume · Oct 20 3.53M Avg daily vol (3M) 2.18M

TMO metrics

117 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$687.37
Market cap
$251.20B

Price action

20 metrics
Price change (1W)
+3.7%
Price change (30D)
+4.3%
Price change (3M)
+31.3%
Price change (6M)
+31.0%
Price change (YTD)
+18.6%
Price change (1Y)
+26.4%
Trailing year
Price change (5Y)
+13.5%
52-week high
$696.49
52-week low
$438.34
Change from 52-week high
-1.3%
Change from 52-week low
+56.8%
Annualized volatility
29.2%
Annualized volatility (3M)
29.9%
Beta
0.6
RSI (14D)
61.3
Price vs SMA 50
+7.4%
Price vs SMA 200
+25.4%
Avg volume (3M)
2.18M
Relative volume
1.6
Average dollar volume
$1.36B

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
369.75M

Valuation

12 metrics
P / E (TTM)
37.0
Trailing earnings · reciprocal yield 2.7%
PEG ratio
4.0
EV / revenue
6.3×
reciprocal yield 16.0%
EV / EBITDA
44.3×
reciprocal yield 2.3%
EV / EBIT
35.6×
reciprocal yield 2.8%
P / sales
5.4×
reciprocal yield 18.4%
P / book
4.8
reciprocal yield 21.0%
FCF yield
2.9%
TTM · current market cap
Buyback yield
2.0%
P / FCF
34.3
reciprocal yield 2.9%
P / operating cash flow
27.9
reciprocal yield 3.6%
Earnings yield
2.8%

Historical valuation

8 metrics
P / E historical average (3Y)
32.0×
reciprocal yield 3.1%
P / E historical average (5Y)
31.1×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
5.3×
reciprocal yield 18.9%
EV / revenue historical average (5Y)
5.5×
reciprocal yield 18.2%
EV / EBIT historical average (3Y)
31.5×
reciprocal yield 3.2%
EV / EBIT historical average (5Y)
29.4×
reciprocal yield 3.4%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.3%
Trailing 12 months
Payout ratio
9.5%
Shareholder yield
2.3%
Dividend / share (TTM)
$1.84
Dividend growth YoY
+9.5%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-15

Earnings calendar

2 metrics
Next earnings
2026-10-21
Last earnings
2026-07-23

Profitability

9 metrics
Gross margin
—
Operating margin
17.6%
Trailing 12 months
Net margin
15.0%
Gross profit (TTM)
$11.33B
Operating profit (TTM)
$8.15B
Net income (TTM)
$6.97B
Trailing 12 months
Diluted EPS (TTM)
$18.59
FCF margin
15.8%
Effective tax rate
7.8%

Per share

11 metrics
Revenue per diluted share (TTM)
$123.65
Gross profit per diluted share (TTM)
$28.11
Operating profit per diluted share (TTM)
$21.74
EBITDA per diluted share (TTM)
$14.90
Net income per diluted share (TTM)
$18.59
Operating cash flow per diluted share (TTM)
$24.01
Free cash flow per diluted share (TTM)
$19.49
Capital expenditures per diluted share (TTM)
$4.52
R&D per diluted share (TTM)
$3.74
Stock compensation per diluted share (TTM)
$0.85
Book value per share
$142.47

Growth

11 metrics
Revenue growth YoY
+10.5%
Year over year
Net income growth YoY
+7.4%
Revenue (TTM)
$46.34B
Trailing 12 months
EPS growth YoY
+9.3%
Shares change YoY
-1.9%
Year over year · fewer shares
Revenue CAGR (3Y)
-0.3%
Revenue CAGR (5Y)
+6.7%
EPS CAGR (3Y)
+0.2%
EPS CAGR (5Y)
+2.1%
FCF CAGR (3Y)
-3.1%
FCF CAGR (5Y)
-1.6%

Quality

14 metrics
Return on equity
13.2%
Return on assets
6.2%
Debt / equity
0.8
Current ratio
1.6
EBITDA (TTM)
$6.05B
Free cash flow (TTM)
$7.32B
Quick ratio
1.2
Interest coverage
—
Net debt / EBITDA
2.8
Return on invested capital
8.2%
Trailing 12 months
Net cash
−$38.48B
Latest balance sheet
Cash & equivalents
$4.06B
Total assets
$113.17B
Total debt
$42.55B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$9.01B
Capital expenditures (TTM)
$1.70B
R&D (TTM)
$1.40B
SG&A (TTM)
$9.03B
Stock compensation (TTM)
$319.00M
R&D / revenue
3.0%
Stock compensation / revenue
0.7%

Ownership (13F)

9 metrics
13F filers
2,637
13F filer change QoQ
+13
Institutional ownership
91.9%
Conviction holders (share of 13F filers)
2.7%
Crowding (high-turnover and private-fund holders)
13.6%
Private-fund adviser ownership
13.0%
Active holders' share change QoQ
-0.8%
Holder tenure
19.2
Price vs estimated holder cost
-1.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.8%

Short interest

3 metrics
Short interest
1.5%
Latest settlement · 2.1 days to cover
Days to cover
2.1d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$61.56M
Insider-sentiment score
29 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 97745 CUSIP 883556102 13F (30d) 651 filings 615 filers Visit website Investor relations